Anoctamin 4 channel currents activate glucose-inhibited neurons in the mouse ventromedial hypothalamus during hypoglycemia
Longlong Tu, Jonathan C. Bean, Yang He, Hailan Liu, Meng Yu, Hesong Liu, Nan Zhang, Na Yin, Junying Han, Nikolas A. Scarcelli, Kristine M. Conde, Mengjie Wang, Yongxiang Li, Bing Feng, Peiyu Gao, Zhao-Lin Cai, Makoto Fukuda, Mingshan Xue, Qingchun Tong, Yongjie Yang, Lan Liao, Jianming Xu, Chunmei Wang, Yanlin He, Yong Xu
Longlong Tu, Jonathan C. Bean, Yang He, Hailan Liu, Meng Yu, Hesong Liu, Nan Zhang, Na Yin, Junying Han, Nikolas A. Scarcelli, Kristine M. Conde, Mengjie Wang, Yongxiang Li, Bing Feng, Peiyu Gao, Zhao-Lin Cai, Makoto Fukuda, Mingshan Xue, Qingchun Tong, Yongjie Yang, Lan Liao, Jianming Xu, Chunmei Wang, Yanlin He, Yong Xu
View: Text | PDF
Research Article Neuroscience

Anoctamin 4 channel currents activate glucose-inhibited neurons in the mouse ventromedial hypothalamus during hypoglycemia

Abstract

Glucose is the basic fuel essential for maintenance of viability and functionality of all cells. However, some neurons — namely, glucose-inhibited (GI) neurons — paradoxically increase their firing activity in low-glucose conditions and decrease that activity in high-glucose conditions. The ionic mechanisms mediating electric responses of GI neurons to glucose fluctuations remain unclear. Here, we showed that currents mediated by the anoctamin 4 (Ano4) channel are only detected in GI neurons in the ventromedial hypothalamic nucleus (VMH) and are functionally required for their activation in response to low glucose. Genetic disruption of the Ano4 gene in VMH neurons reduced blood glucose and impaired counterregulatory responses during hypoglycemia in mice. Activation of VMHAno4 neurons increased food intake and blood glucose, while chronic inhibition of VMHAno4 neurons ameliorated hyperglycemia in a type 1 diabetic mouse model. Finally, we showed that VMHAno4 neurons represent a unique orexigenic VMH population and transmit a positive valence, while stimulation of neurons that do not express Ano4 in the VMH (VMHnon-Ano4) suppress feeding and transmit a negative valence. Together, our results indicate that the Ano4 channel and VMHAno4 neurons are potential therapeutic targets for human diseases with abnormal feeding behavior or glucose imbalance.

Authors

Longlong Tu, Jonathan C. Bean, Yang He, Hailan Liu, Meng Yu, Hesong Liu, Nan Zhang, Na Yin, Junying Han, Nikolas A. Scarcelli, Kristine M. Conde, Mengjie Wang, Yongxiang Li, Bing Feng, Peiyu Gao, Zhao-Lin Cai, Makoto Fukuda, Mingshan Xue, Qingchun Tong, Yongjie Yang, Lan Liao, Jianming Xu, Chunmei Wang, Yanlin He, Yong Xu

×

Figure 6

Optogenetic stimulation of VMHnon–Ano4 neurons suppresses food intake and induces a negative valance.

Options: View larger image (or click on image) Download as PowerPoint
Optogenetic stimulation of VMHnon–Ano4 neurons suppresses food intake an...
(A) Schematic representation of injection of pAAV-EF1a-DO-hChR2 (H134R)-mCherry into the VMH and implantation of optical fiber in Ano4-P2A-Cre mice (male, 8–12 weeks of age). (B and C) Effects of optogenetic stimulation of VMHnon–Ano4 neurons on food intake in satiated (B) and fasted (C) condition mice (n = 9). (D–K) Effects of optogenetic activation of VMHnon–Ano4 neurons on blood glucose level in a basal state (D–E), in GTT(F and G), in ITT (H-I), or 2-DG–induced glucopenia (J–K) (n = 9). L–N. Time spent, distance travelled, and velocity in each respective chamber for Ano4-P2A-Cre mice with injection of pAAV-EF1a-DO-hChR2 (H134R)-mCherry into the VMH during real-time place preference test (n = 9). (O–Q). Distance travelled, velocity, and time spent in the center for Ano4-P2A-Cre mice with injection of pAAV-EF1a-DO-hChR2 (H134R)-mCherry into the VMH during open field test. BS refers to baseline (n = 9). Data are expressed as mean ± SEM. Significant differences between groups are shown as *P < 0.05, **P < 0.01, and ***P < 0.001 (2-tailed paired Student’s t test for B, C, E, O, and P, and 2-tailed unpaired Student’s t test for L and M). Red arrows indicate where glucose (F), insulin (H) or 2-DG (J) was injected.